DMD and Duchenne muscular dystrophy: Comprehensive characterisation of the respiratory control system at end‐stage disease in pre‐clinical models of DMD such as D2.mdx and dystrophin/utrophin double knockout mdx/utrn–/– mice (Delaney & O'Halloran, 2024) is required to provide a platform to test existing and emerging therapies to mitigate respiratory system dysfunction.